# 2314 Hyperamylasemia in Neurosurgical Patients.
Katherine J. M. Liu, Mary Jo Atten, Debra Hawkins, Evageline
Panizales, Moon Ja Cho, Terry Lichtor, James Stone, Philip E.
Donahue, Chicago, IL
Hyperamylasemia of pancreatic origin has been observed in neurosurgical
patients in the absence of clinical pancreatitis. However, the clinical conditions
associated with this hyperamylasemia are unclear. Hence, we evaluated
these neurosurgical patients to identify the clinical significance of
pancreatic enzyme elevations in neurosurgical patients.
Methods and Results: We retrospectively reviewed the charts of patients
who were admitted to Cook County Hospital Neurosurgical ICU over a 4
month period. Seventy-four consecutively admitted patients were divided
into two groups: Group I (n=63) had normal serum amylase and lipase
levels throughout the entire hospitalization, and Group II (n=11) had both
serum amylase and lipase elevations at some point during the hospitalization.
Twenty-three of the Group I (36%), and 10 of the Group II (91%)
patients underwent craniotomy (p<0.001). Ten of the Group I (16%), and
7 of the Group II (64%) patients required craniotomy for intracranial bleeding
(p<0.01). In Group II patients, mean serum amylase levels were 402 ±
444 U/L (Mean ± SD), range of 106-1743 (nl£75), and lipase levels were 474
± 313 I.U. (Mean ± SD), range of 176-1385 (nl£55). On average, serum
amylase and lipase elevations were noted on the 9th day post-craniotomy
(range 5-18 days), and both enzymes peaked on the same day in 8 of the 11
patients (73%), unlike the delayed peak of serum lipase seen in patients
with true pancreatic inflammation. No clinical or radiographic evidence of
pancreatitis was otherwise found. Medications, as well as feeding routes
and formulations, were similar in the two groups.
Conclusions: The severity of the intracranial event and need for craniotomy
appear to be the most important factors associated with serum amylase
and lipase elevations, particularly in the case of intracranial bleeding requiring
craniotomy and clot evacuation. Increased vagal activity, altered
sympathetic adrenergic tone, hormonal stimulation, and/or release of
cytokines are possible mechanisms for the pancreatic enzyme elevation.
The elevated serum amylase and lipase do not appear to be associated with
any pathological process in the pancreas. Therefore, extensive work-up,
creating significant costs and undue delays in enteral nutrition, is not warranted
in these patients.
|